C. Evan Ballantyne
2013 - Synthetic Biologics
In 2013, C. Evan Ballantyne earned a total compensation of $393.6K as Former Chief Financial Officer at Synthetic Biologics, a 71% decrease compared to previous year.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Salary | $298,000 |
| Other | $15,579 |
| Total | $393,579 |
Ballantyne received $298K in salary, accounting for 76% of the total pay in 2013.
Ballantyne also received $80K in bonus and $15.6K in other compensation.
Rankings
In 2013, C. Evan Ballantyne's compensation ranked 10,099th out of 12,286 executives tracked by ExecPay. In other words, Ballantyne earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,099 out of 12,286 | 18th |
Division Manufacturing | 3,755 out of 4,612 | 19th |
Major group Chemicals And Allied Products | 1,200 out of 1,466 | 18th |
Industry group Drugs | 941 out of 1,160 | 19th |
Industry Pharmaceutical Preparations | 730 out of 890 | 18th |
Source: SEC filing on July 6, 2016.
Ballantyne's colleagues
We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2013.
2013
Jeffrey Riley
Synthetic Biologics